Cost studies on dialysis therapy in the world: a systematic review and a historical approach

• Autor(a) principal: Schreider, Alyne
• Data de Publicação: 2019
• Outros Autores: de Souza Neto, Manoel Francisco, Paula Pereira, Juliana, Maria da Silva Fernandes, Natalia
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: HU Revista (Online)
• Texto Completo: https://periodicos.ufjf.br/index.php/hurevista/article/view/28663
• topic: Costs and Cost Analyses; Health Expenditures; Peritoneal Dialysis; Renal Dialysis; Custos e Análise de Custo; Gastos em Saúde; Diálise Peritoneal; Diálise Renal

Introduction: Kidney disease affects 850 million people worldwide and is a major contributor to the global burden of noncommunicable diseases (NCDs). By 2040 it is projected to be the fifth cause of lost years of life. The aim of this review is to evaluate where (geographically) and how cost studies on dialysis therapy are being done in the world. Material and methods: A search was carried out on 06/26/2017, 07/10/2017 and 09/30/2018 with the keywords “cost and cost analysis”, ”health expenditures” and “peritoneal dialysis”. The same keywords and “renal dialysis” in Pubmed, Scielo and EmBase databases and 1796 articles were found, of which 124 were selected. We added analysis in academic google. At the end we analyzed 125 articles. The inclusion criteria of the articles were the scope of the study cost, using various methodologies such as cost, total cost, cost effectiveness, cost utility, cost benefit, cost minimization, expense, economic impact. The perspective could be from the payer and the service provider. Results: We observed a greater number of publications from the year 2000. Regarding the design of the studies, most presented a difficult to reproduce methodology with different concepts and different method. There were great variability across countries and even between dialysis centers. Overall, in high-income countries, continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) are less expensive than HD (hemodialysis). In Brazil most studies show HD presenting lower cost than CAPD and APD. Conclusion: Cost studies are recent in the literature, include several methods and the description of the results is not standardized. The designs are diverse and generally show the perspective of the payer. We hope to progress to a value-based health discussion.